THERMA BRIGHT INC (THRM.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:THRM - CA8834262070 - Common Stock
THRM.CA Key Statistics, Chart & Performance
The current stock price of THRM.CA is 0.05 CAD. In the past year, price decreased by -84.37%.
THRM.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PRN.CA | PROFOUND MEDICAL CORP | N/A | 321.52M | ||
| TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 50.79M | ||
| MIR.CA | MEDMIRA INC | N/A | 49.29M | ||
| PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 41.20M | ||
| VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 21.80M | ||
| NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 19.68M | ||
| ASG.CA | AURORA SPINE CORP | N/A | 19.30M | ||
| MDX.CA | MEDX HEALTH CORP | N/A | 18.04M | ||
| VER-H.CA | VERISANTE TECHNOLOGY INC | N/A | 878.80K | ||
| CNVI.CA | CONAVI MEDICAL CORP | N/A | 36.46M | ||
| VVTM.CA | VVT MED INC | N/A | 20.05M |
Related stock screener links
About THRM.CA
Company Profile
Therma Bright, Inc. engages in developing and marketing skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The firm is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on three key strategic areas: respiratory disease, vascular health and consumer medical devices. Its respiratory disease portfolio includes AI4LYF Digital Cough Technology and InStatin-novel inhaled treatment for asthma and COPD. Its vascular disease portfolio includes Inretio-ischemic stroke treatment and Venowave-Deep Vein Thrombosis Treatment Device (DVT). Its consumer health portfolio consists of AcuVid Covid-19 Rapid Antigen Saliva Test, Benepod-Contrast Therapy Device, TheroZAP-Thermal Therapy Device and InterceptCS-Cold Sore Prevention System. The firm holds trademarks for Therozap, InterceptCS and AcuVid.
Company Info
THERMA BRIGHT INC
345 Danforth Avenue
TORONTO ONTARIO M4M 3P1 CA
CEO: Rob Fia
Employees: 0
Phone: 18442746837
THERMA BRIGHT INC / THRM.CA FAQ
What does THRM do?
Therma Bright, Inc. engages in developing and marketing skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The firm is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on three key strategic areas: respiratory disease, vascular health and consumer medical devices. Its respiratory disease portfolio includes AI4LYF Digital Cough Technology and InStatin-novel inhaled treatment for asthma and COPD. Its vascular disease portfolio includes Inretio-ischemic stroke treatment and Venowave-Deep Vein Thrombosis Treatment Device (DVT). Its consumer health portfolio consists of AcuVid Covid-19 Rapid Antigen Saliva Test, Benepod-Contrast Therapy Device, TheroZAP-Thermal Therapy Device and InterceptCS-Cold Sore Prevention System. The firm holds trademarks for Therozap, InterceptCS and AcuVid.
What is the stock price of THERMA BRIGHT INC today?
The current stock price of THRM.CA is 0.05 CAD. The price decreased by -9.09% in the last trading session.
Does THRM stock pay dividends?
THRM.CA does not pay a dividend.
What is the ChartMill rating of THERMA BRIGHT INC stock?
THRM.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the PE ratio for THRM stock?
THERMA BRIGHT INC (THRM.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.07).
Can you provide the ownership details for THRM stock?
You can find the ownership structure of THERMA BRIGHT INC (THRM.CA) on the Ownership tab.
THRM.CA Technical Analysis
THRM.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to THRM.CA. Both the profitability and financial health of THRM.CA have multiple concerns.
THRM.CA Financial Highlights
Over the last trailing twelve months THRM.CA reported a non-GAAP Earnings per Share(EPS) of -0.07. The EPS decreased by -25.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1021.89% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |